1.84
Spectral Ai Inc stock is traded at $1.84, with a volume of 230.79K.
It is up +1.10% in the last 24 hours and down -24.28% over the past month.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.
See More
Previous Close:
$1.82
Open:
$1.875
24h Volume:
230.79K
Relative Volume:
0.25
Market Cap:
$58.56M
Revenue:
$16.70M
Net Income/Loss:
$-14.29M
P/E Ratio:
-3.4412
EPS:
-0.5347
Net Cash Flow:
$-12.14M
1W Performance:
-0.54%
1M Performance:
-24.28%
6M Performance:
+23.49%
1Y Performance:
-6.60%
Spectral Ai Inc Stock (MDAI) Company Profile
Name
Spectral Ai Inc
Sector
Industry
Phone
(212) 492-3000
Address
2515 MCKINNEY AVE #1000, DALLAS
Compare MDAI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MDAI
Spectral Ai Inc
|
1.84 | 58.56M | 16.70M | -14.29M | -12.14M | -0.5347 |
|
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Spectral Ai Inc Stock (MDAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-24 | Initiated | BTIG Research | Buy |
Spectral Ai Inc Stock (MDAI) Latest News
China's Top Multispectral AI Firm Shenzhen HQVT Advances Hong Kong IPO - TradingView
Number of shareholders of Spectral AI, Inc. – NASDAQ:MDAIW - TradingView
Spectral AI joins wound healing awareness campaign - Investing.com
Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month - The Manila Times
Spectral AI Celebrates Wound Healing Awareness Month in Partnership with ABWM Foundation - Quiver Quantitative
Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound ... - Enidnews.com
Spectral AI to Participate in 2026 British Burn Association Annual Conference - The Manila Times
AI burn device gauges healing in 21 days at British Burn meet - Stock Titan
SPECTRAL AI INC (MDAI) Stock Chart - ChartMill
FDA clears Spectral AI (Nasdaq: MDAI) DeepView burn system as shareholders back all 2026 proposals - Stock Titan
Spectral AI (MDAI) director DiMaio reports new stock grants and options - Stock Titan
Spectral AI Announces Voting Results of Annual Meeting of Stockholders - The Manila Times
AI burn-scan cleared by FDA as Spectral AI targets first sales - Stock Titan
MDAI: DeepView FDA Clearance Fires Up Our Valuation - Yahoo Finance
Spectral AI Receives FDA Clearance for DeepView Burn System - D Magazine
Spectral AI, Inc.Warrants (NQ: MDAIW - FinancialContent
FDA Grants De Novo OK to Spectral AI’s DeepView System - Medical Product Outsourcing
Analysts Offer Insights on Healthcare Companies: Spectral AI (MDAI), NeOnc Technologies Holdings, Inc. (NTHI) and Innoviva (INVA) - The Globe and Mail
Spectral AI (NASDAQ: MDAI) director granted 32,233 shares and holds options - Stock Titan
Spectral AI Inc. (MDAI) Edges Lower as Stock Consolidates Near Support ZoneIchimoku Cloud - thelegaladvocate.com
MDAI Maintained by BTIG -- Price Target Raised to $4.00 - GuruFocus
Spectral AI, Inc. [MDAI NQ]: FDA De Novo Classification granted for DeepView® system for burn indication - London South East
FDA clears Spectral AI (NASDAQ: MDAI) DeepView burn device - Stock Titan
Spectral AI (MDAI) Receives FDA De Novo Classification for DeepV - GuruFocus
BTIG raises Spectral AI stock price target to $4 on FDA clearance - Investing.com Nigeria
BTIG raises Spectral AI stock price target to $4 on FDA clearance By Investing.com - Investing.com South Africa
Spectral AI receives FDA De Novo clearance for burn wound system By Investing.com - Investing.com South Africa
Spectral AI receives FDA De Novo clearance for burn wound system - Investing.com
Spectral Ai Receives FDA De Novo Clearance for DeepView System for Burn Indication - marketscreener.com
AI imaging system now helps doctors judge burn healing in under 30 seconds - Stock Titan
Spectral Ai receives FDA De Novo clearance for Deepview® system for burn indication - marketscreener.com
Spectral Ai Receives FDA De Novo Clearance For Deepview® System For Burn Indication - TradingView
Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication - GlobeNewswire
Spectral AI Q1 earnings call highlights - MSN
Wiley expands mass spectral database to support AI-assisted chemical analysis - Wiley Analytical Science
Spectral AI (MDAI) director awarded 25,000 shares and reports vested options - Stock Titan
Spectral AI (NASDAQ: MDAI) director granted additional common shares and options - Stock Titan
Spectral AI (MDAI) director granted additional common shares and options - Stock Titan
MDAI Technical Analysis & ETF Price Forecast - Intellectia AI
Earnings call transcript: Spectral AI Q1 2026 reveals mixed results, stock dips - Investing.com Nigeria
Analyst Estimates: Here's What Brokers Think Of Spectral AI, Inc. (NASDAQ:MDAI) After Its First-Quarter Report - simplywall.st
MDAI: First Quarter 2026 Results - Yahoo Finance
BTIG Maintains Spectral AI(MDAI.US) With Buy Rating, Maintains Target Price $3 - Moomoo
Spectral AI reports net loss of USD 3.4M in Q1 2026 - Medical Buyer
Spectral AI, Inc. 2026 Q1 Financial Report: DeepView Burn Diagnostics, Financial Results, and Risk Analysis - Minichart
Spectral AI Q1 Earnings Call Highlights - inkl
MDAI: FDA response and BARDA funding drive 2026 outlook; DeepView commercialization targeted late 2026 - TradingView
MDAI: FDA response and DeepView commercialization expected in 2026; BARDA funding drives growth - TradingView
Spectral Ai Inc Stock (MDAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):